Form 8-K - Current report:
SEC Accession No. 0001792044-25-000004
Filing Date
2025-02-27
Accepted
2025-02-27 07:38:46
Documents
15
Period of Report
2025-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtrs-20250227.htm   iXBRL 8-K 26199
2 EX-99.1 exhibit991-4q24earningsrel.htm EX-99.1 644048
6 picture2a.jpg GRAPHIC 4362
  Complete submission text file 0001792044-25-000004.txt   849876

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtrs-20250227.xsd EX-101.SCH 1807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtrs-20250227_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtrs-20250227_pre.xml EX-101.PRE 12532
17 EXTRACTED XBRL INSTANCE DOCUMENT vtrs-20250227_htm.xml XML 2708
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 25673058
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)